The Enterprise Value as of December 2025 (TTM) for Salarius Pharmaceuticals, Inc. (SLRX) is 293.35K

According to Salarius Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 293.35K. This represents a change of -142.14% compared to the average of -696041.68 of the last 4 quarters.

Salarius Pharmaceuticals, Inc. (SLRX) Historical Enterprise Value (quarterly & annually)

How has SLRX Enterprise Value performed in the past?

The mean historical Enterprise Value of Salarius Pharmaceuticals, Inc. over the last ten years is 76.46B. The current 293.35K Enterprise Value has changed -99.96% with respect to the historical average. Over the past ten years (40 quarters), SLRX's Enterprise Value was at its highest in in the March 2018 quarter at 449.56B. The Enterprise Value was at its lowest in in the June 2022 quarter at -11376935.00.

Salarius Pharmaceuticals, Inc. (SLRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Salarius Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Salarius Pharmaceuticals, Inc. (SLRX) Average Enterprise Value

How has SLRX Enterprise Value performed in the past?

The current Enterprise Value of Salarius Pharmaceuticals, Inc. (SLRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Salarius Pharmaceuticals, Inc. (SLRX) Enterprise Value vs. Peers

How is SLRX’s Enterprise Value compared to its peers?

Salarius Pharmaceuticals, Inc.’s Enterprise Value is greater than SciSparc Ltd. (-572623.00), greater than Indaptus Therapeutics, Inc. (-2376149.00), less than GT Biopharma, Inc. (4.16M), less than Silexion Therapeutics Ltd. (2.01M), greater than Avenue Therapeutics, Inc. (-1162154.00), greater than Revelation Biosciences, Inc. (-6784353.00), greater than Lipella Pharmaceuticals Inc. (-1590260161.00), less than Enveric Biosciences, Inc. (797.72K), less than NKGen Biotech, Inc. Common Stock (4.60M), greater than Psyence Biomedical Ltd. (-4844216.00),

Build a custom stock screener for Salarius Pharmaceuticals, Inc. (SLRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Salarius Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Salarius Pharmaceuticals, Inc. (SLRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Salarius Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.